In drug-refractory IBS, group CBT with interoceptive exposure improved symptoms and QoL at 13 wk

Daniel Oliver; Nicholas J Talley

doi:10.7326/J22-0054

In drug-refractory IBS, group CBT with interoceptive exposure improved symptoms and QoL at 13 wk

Ann Intern Med. 2022 Aug;175(8):JC90. doi: 10.7326/J22-0054. Epub 2022 Aug 2.

Authors

Daniel Oliver¹, Nicholas J Talley¹

Affiliation

¹ University of Newcastle and John Hunter Hospital, Newcastle, New South Wales, Australia (D.O., N.J.T.).

PMID: 35914262
DOI: 10.7326/J22-0054

Abstract

Kikuchi S, Oe Y, Ito Y, et al. Group cognitive-behavioral therapy with interoceptive exposure for drug-refractory irritable bowel syndrome: a randomized controlled trial. Am J Gastroenterol. 2022;117:668-77. 35103022.

Publication types

Randomized Controlled Trial
Comment

MeSH terms

Cognitive Behavioral Therapy*
Humans
Irritable Bowel Syndrome* / therapy
Quality of Life
Treatment Outcome